PHARMACOKINETICS AND ENTEROHEPATIC CIRCULATION OF (E)-2-ENE VALPROIC ACID IN THE RAT

被引:9
作者
SINGH, K [1 ]
ORR, JM [1 ]
ABBOTT, FS [1 ]
机构
[1] UNIV BRITISH COLUMBIA,FAC PHARMACEUT SCI,VANCOUVER V6T 1W5,BC,CANADA
来源
JOURNAL OF PHARMACOBIO-DYNAMICS | 1990年 / 13卷 / 10期
关键词
(E)-2-ene valproic acid; biliary excretion; enterohepatic circulation; pharmacokinetics; rat;
D O I
10.1248/bpb1978.13.622
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A pharmacologically active monounsaturated metabolite of valproic acid (VPA), (E)-2-ene VPA, was administered by an intravenous bolus dose of 20 mg/kg to normal and bile-exteriorized rats. The total plasma clearance of (E)-2-ene VPA in normal rats was 4.9 ml/min/kg and in bile-exteriorized rats, 7.7 ml/min/kg. (E)-2-ene was recycled in the plasma of normal rats due to enterohepatic circulation. Approximately 32% of the dose was excreted in the urine of normal rats. Of the administered dose to bile exteriorized rats, approximately 27% was excreted in the urine and 38% in the bile. Administration of (E)-2-ene increased bile flow rate, and the induced choleresis lasted for 3—4 h. (E)-2-ene VPA was largely excreted in apparently conjugated form in the urine and bile. The pharmacokinetics of (E)-2-ene VPA were similar to that of the parent drug VPA. © 1990, The Pharmaceutical Society of Japan. All rights reserved.
引用
收藏
页码:622 / 627
页数:6
相关论文
共 27 条
[1]   CAPILLARY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY OF VALPROIC ACID METABOLITES IN SERUM AND URINE USING TERT-BUTYLDIMETHYLSILYL DERIVATIVES [J].
ABBOTT, FS ;
KASSAM, J ;
ACHEAMPONG, A ;
FERGUSON, S ;
PANESAR, S ;
BURTON, R ;
FARRELL, K ;
ORR, J .
JOURNAL OF CHROMATOGRAPHY, 1986, 375 (02) :285-298
[2]   IDENTIFICATION OF VALPROIC ACID METABOLITES IN HUMAN-SERUM AND URINE USING HEXADEUTERATED VALPROIC ACID AND GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC ANALYSIS [J].
ACHEAMPONG, A ;
ABBOTT, F ;
BURTON, R .
BIOMEDICAL MASS SPECTROMETRY, 1983, 10 (11) :586-595
[3]   PHARMACOKINETICS OF VALPROIC ACID IN VOLUNTEERS AFTER A SINGLE DOSE STUDY [J].
BIALER, M ;
HUSSEIN, Z ;
RAZ, I ;
ABRAMSKY, O ;
HERISHANU, Y ;
PACHYS, F .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1985, 6 (01) :33-42
[5]   SODIUM VALPROATE - MONOTHERAPY AND POLYTHERAPY [J].
COVANIS, A ;
GUPTA, AK ;
JEAVONS, PM .
EPILEPSIA, 1982, 23 (06) :693-720
[6]  
DICKINSON RG, 1979, J PHARMACOL EXP THER, V211, P583
[7]   OPEN TRIALS WITH VALPROATE IN EPILEPSY [J].
DULAC, O ;
ARTHUIS, M .
EPILEPSIA, 1984, 25 :S23-S31
[8]   ASPECTS OF THE METABOLISM OF VALPROIC ACID [J].
GRANNEMAN, GR ;
WANG, SI ;
MACHINIST, JM ;
KESTERSON, JW .
XENOBIOTICA, 1984, 14 (05) :375-387
[9]  
GRANNEMAN GR, 1986, METABOLISM ANTIEPILE, P97
[10]  
KEANE PE, 1985, METHOD FIND EXP CLIN, V7, P83